Medication Comparison
Wegovy vs Saxenda
Wegovy is the clear upgrade over Saxenda — nearly twice the weight loss (~15% vs ~8%) with weekly instead of daily injections. Both are FDA-approved for weight management. Saxenda remains relevant for adolescents and when Wegovy is unavailable.
| Category | Wegovy | Saxenda |
|---|---|---|
| Brands | Wegovy (semaglutide 2.4mg) | Saxenda (liraglutide 3mg) |
| Class | GLP-1 RA | GLP-1 RA |
| Administration | Weekly injection | Daily injection |
| Average weight loss | ~15% | ~8% |
| Compounded cost | $1,300-1,400/mo (brand) | $1,300-1,500/mo (brand) |
| Brand cost | $1,300-1,400/mo | $1,300-1,500/mo |
| Half-life | ~7 days | ~13 hours |
| Dosing frequency | Once weekly | Once daily |
| Key trial | STEP 1 (16.9% weight loss) | SCALE (8% weight loss) |
Best for Wegovy
Most adults seeking FDA-approved weight management with maximum efficacy
Best for Saxenda
Adolescents (12+) or patients who cannot access Wegovy due to supply issues
Wegovy tradeoffs
Pros
- Nearly twice the weight loss
- Weekly dosing
- Cardiovascular benefit proven
Cons
- Newer medication
- Supply shortages
Saxenda tradeoffs
Pros
- Longer safety track record
- Approved for adolescents 12+
- More available (less shortage)
Cons
- Daily injections
- Roughly half the weight loss
- First-generation GLP-1
Common questions
Should I switch from Saxenda to Wegovy?
If you want greater weight loss with less frequent injections, Wegovy is the upgrade. Discuss with your doctor — they'll typically start you at the lowest Wegovy dose and titrate up.
Are Wegovy and Saxenda the same thing?
No. Wegovy contains semaglutide (newer, more potent) while Saxenda contains liraglutide (older, first-generation). Both are GLP-1 receptor agonists but different molecules.
Which has better insurance coverage?
Coverage varies by plan. Both are approved for weight management, but Saxenda has been available longer and may be on more formularies. Always check your specific plan.
Compare clinics that prescribe these medications
Use provider pages to compare clinical oversight, medication source, and pricing transparency before starting.
Related comparisons